How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials

Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.30.2174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

A Systematic Review of Gemcitabine and Taxanes Combination Therapy Randomized Trials for Metastatic Breast Cancer

SpringerPlus
Multidisciplinary
2014English

Worst-Case Scenarios for American Options

International Journal of Theoretical and Applied Finance
EconomicsEconometricsFinance
2000English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

“How Long Have I Got?”—A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients With Advanced Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

A Systematic Review of the Clinical Effectiveness of First-Line Chemotherapy for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Thorax
PulmonaryRespiratory Medicine
2015English

Herbal Medicine for Xerostomia in Cancer Patients: A Systematic Review of Randomized Controlled Trials

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2017English

Assessing the Tolerability and Efficacy of First-Line Chemotherapy in Elderly Patients With Metastatic HER2−ve Breast Cancer

ecancermedicalscience
Cancer ResearchOncology
2019English

Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer

Journal of Cancer
Oncology
2020English

Minimizing Worst-Case and Average-Case Makespan Over Scenarios

Journal of Scheduling
Management ScienceEngineeringOperations ResearchArtificial IntelligenceSoftware
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy